HOX Genes in Cancer
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (31 March 2019) | Viewed by 59850
Special Issue Editors
Interests: HOX genes; transcriptional regulation; PBX genes; HXR9
Interests: HOX genes; head and neck cancer; oral pathology; microRNA
Special Issue Information
Dear Colleagues,
The HOX genes are a family of transcription factors that play key roles in conferring cell and tissue identity during early development, but which are also frequently expressed at very high levels in a wide range of solid and hematological cancers. Over the last decade is has become apparent that the HOX genes can promote oncogenesis and the maintenance of a malignant phenotype, and are therefore potential therapeutic targets in cancer as well as biomarkers for diagnosis, prognosis, and patient stratification. This Special Issue, HOX Genes in Cancer, will provide a forum for the latest discoveries in this rapidly expanding field, and help make it accessible through reviews on key topics including the role of HOX genes in cancer stem cells, current progress on targeting HOX proteins in cancer, the cancer-specific functions of HOX genes, and the potential of HOX genes and their products as biomarkers.
Prof. Dr. Richard Morgan
Prof. Dr. Keith D. Hunter
Dr. Alex Thompson
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HOX
- PBX
- cancer
- HXR9
- cancer stem cells
- oncogenesis
- biomarker